Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Leo Stone currently holds 2,352,500 shares of LianBio (LIAN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Leo Stone has been a net neutral trader of LIAN stock. They have purchased $0 and sold $0 worth of shares.
Adam Leo Stone's most recent insider trade was on Jul 20, 2026, when they sold 2,066,250 shares at $0.00 per share.
Adam Leo Stone serves as Executive at LianBio (LIAN). They have executed 15 insider transactions totaling $0 over their tenure at the company.
Adam Leo Stone holds the position of Executive at LianBio, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Adam Leo Stone has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Adam Leo Stone was on Jul 15, 2021, when they purchased $5.0M worth of ARYE shares. This transaction involved 499,000 shares at $10.00 per share.
Adam Leo Stone currently owns 2,352,500 shares of LianBio (LIAN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Leo Stone's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Leo Stone has 15 Form 4 filings on record as an insider at LianBio.
Set alerts for Adam Leo Stone and 40,000+ other insiders.